Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TYRO protein tyrosine kinase-binding protein (TYROBP), also widely known as DNAX-activation protein 12 (DAP12), is a key transmembrane signaling adaptor protein predominantly expressed in myeloid cells, including microglia, macrophages, dendritic cells, and osteoclasts. It contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain, which is critical for recruiting and activating spleen tyrosine kinase (Syk) and ZAP-70 to initiate downstream signaling cascades like PI3K/Akt and MAPK. TYROBP does not possess an extracellular ligand-binding domain of its own; instead, it non-covalently pairs with various activating cell-surface receptors, most notably triggering receptor expressed on myeloid cells 2 (TREM2) and TREM1, to orchestrate immune responses, phagocytosis, and cell survival.
In disease states, TYROBP-mediated signaling is heavily implicated in neurodegenerative disorders such as Alzheimer's disease, where the TREM2-TYROBP axis regulates microglial clearance of amyloid-beta plaques. Mutations in TYROBP lead to Nasu-Hakola disease (PLOSL), a rare genetic disorder characterized by presenile dementia and bone cysts. Therapeutic strategies targeting this pathway include TREM2-activating antibodies (e.g., AL002) and small-molecule molecular glues (e.g., VG-3927) that stabilize the TREM2-TYROBP complex to enhance microglial function. Conversely, inhibitors of DAP12 dimerization or multimerization (such as SRI-44049 and H151-AL) are being explored to mitigate hyper-inflammatory responses in conditions like rheumatoid arthritis and acute inflammation.
Drugs targeting the TYROBP/DAP12 pathway act either as agonists that stabilize the TREM2-TYROBP complex to activate downstream ITAM signaling, or as inhibitors that block DAP12 dimerization and multimerization to suppress inflammatory signaling.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TYRO protein tyrosine kinase-binding protein (TYROBP) (TYROBP).